These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9815521)
21. [Cancer risk under hormone therapy]. Lauritzen C Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334 [TBL] [Abstract][Full Text] [Related]
22. Editorial: Cancer risk and estrogen use in the menopause. Ryan KJ N Engl J Med; 1975 Dec; 293(23):1199-200. PubMed ID: 1186792 [TBL] [Abstract][Full Text] [Related]
24. Progestogen deficiency and endometrial cancer risk. Schindler AE Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117 [TBL] [Abstract][Full Text] [Related]
25. Potential benefits of estrogens and progestogens on breast cancer. Schneider HP; Jackisch C Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536 [TBL] [Abstract][Full Text] [Related]
26. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Persson I; Yuen J; Bergkvist L; Schairer C Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404 [TBL] [Abstract][Full Text] [Related]
27. [Current views on the epidemiology and etiology of endometrial carcinoma]. Kaiser R; Schulz KD Gynakologe; 1983 Jun; 16(2):82-6. PubMed ID: 6350118 [TBL] [Abstract][Full Text] [Related]
28. [Estrogen therapy and carcinoma of the endometrium (author's transl)]. Völker W; Kannengiesser U; Majewski A; Vasterling HW Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085 [TBL] [Abstract][Full Text] [Related]
29. [Hormone substitution in patients after primary treatment of gynecologic malignancies]. Petru E; Lahousen M; Urdl W; Luschin G; Pickel H Wien Med Wochenschr; 1993; 143(21):539-41. PubMed ID: 8146998 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for endometrial cancer at different ages. La Vecchia C; Franceschi S; Decarli A; Gallus G; Tognoni G J Natl Cancer Inst; 1984 Sep; 73(3):667-71. PubMed ID: 6590913 [TBL] [Abstract][Full Text] [Related]
32. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician. Berger GS; Fowler WC J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690 [TBL] [Abstract][Full Text] [Related]
33. Links between hormone replacement therapy and neoplasia. Hulka BS Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013 [TBL] [Abstract][Full Text] [Related]
34. The relationship of estrogen and progesterone to breast disease. Brooks PG J Reprod Med; 1984 Jul; 29(7 Suppl):530-8. PubMed ID: 6481706 [TBL] [Abstract][Full Text] [Related]
35. The role of hormones in the etiology and prevention of endometrial cancer. Gambrell RD Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826 [TBL] [Abstract][Full Text] [Related]
36. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
37. Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. Harris BS; Bishop KC; Kuller JA; Ford AC; Muasher LC; Cantrell SE; Price TM Menopause; 2020 Feb; 27(2):243-248. PubMed ID: 31738735 [TBL] [Abstract][Full Text] [Related]
38. Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Cramer DW; Knapp RC Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641 [TBL] [Abstract][Full Text] [Related]
39. Interaction of drugs, hormones, and nutrition in the causes of cancer. Lipsett MB Cancer; 1979 May; 43(5 Suppl):1967-81. PubMed ID: 376102 [TBL] [Abstract][Full Text] [Related]